Clinical Utility of a Genomic Predictor Test on the Management of Cardiorenal Complications of Type 2 Diabetes
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2714 participants.
Also called NCT06586203
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 2,714 participants
- Sponsor
- Optithera
- Registry
-
NCT06586203
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Canada
- Registry status
- Recruiting
Technical summary
Registry record NCT06586203. Randomized; double masking; primary purpose prevention. Start 2024-08-23 (actual); primary completion 2027-08-23 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Utility of a Genomic Predictor Test on the Management of Cardiorenal Complications of Type 2 Diabetes
- Acronym
- GENOCORDIA
- Condition
- Diabetes Mellitus, Type 2
- Condition
- Cardiovascular Diseases
- Condition
- Diabetic Nephropathy Type 2
- Intervention (Device)
- Polygenic Risk Score
- Lead sponsor
- Optithera
- Collaborator
- Genome Quebec
- Collaborator
- Genome Canada
- Collaborator
- ELNA Medical
Record details
- Record id
cardio:ct-nct06586203- Content hash
bae05092718d7fde7ac3ff40334d60a41ea1ddb5dd7fdca2eb436f55c46fd069